In Vitro Activity of Chlorhexidine Compared with Seven Antifungal Agents against 98 Fusarium Isolates Recovered from Fungal Keratitis Patients
暂无分享,去创建一个
M. Burton | C. Oliveira dos Santos | P. Verweij | A. Al‐Hatmi | E. Kolwijck | H. V. D. van der Lee | C. Eggink | M. Tehupeiory-Kooreman | Einoti Matayan
[1] M. Ghannoum,et al. International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method , 2015, Antimicrobial Agents and Chemotherapy.
[2] T. Boekhout,et al. Phylogenetic diversity of human pathogenic Fusarium and emergence of uncommon virulent species. , 2015, The Journal of infection.
[3] Jing Lin,et al. Natamycin in the treatment of fungal keratitis: a systematic review and Meta-analysis. , 2015, International journal of ophthalmology.
[4] C. Kaufmann,et al. Corneal Penetration of Polyhexamethylene Biguanide and Chlorhexidine Digluconate , 2015 .
[5] B. Sampaio-Maia,et al. Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification , 2015, European Journal of Clinical Microbiology & Infectious Diseases.
[6] Jennifer R. Evans,et al. Medical interventions for fungal keratitis. , 2015, The Cochrane database of systematic reviews.
[7] J. Meis,et al. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex. , 2014, The Journal of antimicrobial chemotherapy.
[8] T. Lietman,et al. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis. , 2014, Ophthalmology.
[9] Springer-Verlag,et al. Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment , 2013, European Journal of Clinical Microbiology & Infectious Diseases.
[10] M. Srinivasan,et al. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. , 2013, JAMA ophthalmology.
[11] P. Thomas,et al. Mycotic keratitis: epidemiology, diagnosis and management. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[12] I. Kaur,et al. Topical delivery of antifungal agents , 2010, Expert opinion on drug delivery.
[13] M. Srinivasan,et al. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. , 2010, Archives of ophthalmology.
[14] Subcommittee on Antifungal Susceptibility Testing. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[15] G. Keshava,et al. Mycotic keratitis: an overview of diagnosis and therapy , 2008, Mycoses.
[16] C. Gianni,et al. Species Distribution and In Vitro Antifungal Susceptibility Patterns of 75 Clinical Isolates of Fusarium spp. from Northern Italy , 2008, Antimicrobial Agents and Chemotherapy.
[17] E. Mellado,et al. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. , 2008, The Journal of antimicrobial chemotherapy.
[18] D. Denning,et al. EUCAST DEFINITIVE DOCUMENT E.DEF 9.1: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds , 2008 .
[19] S. Tuli,et al. Fungal Keratitis: Emerging Trends and Treatment Outcomes , 2006, Eye & contact lens.
[20] J. Graybill,et al. Key issues concerning fungistatic versus fungicidal drugs , 2005, European Journal of Clinical Microbiology and Infectious Diseases.
[21] M. Srinivasan,et al. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis , 2003, The British journal of ophthalmology.
[22] A. D. Russell,et al. Antiseptics and Disinfectants: Activity, Action, and Resistance , 1999, Clinical Microbiology Reviews.
[23] G. Johnson,et al. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh , 1998, The British journal of ophthalmology.
[24] G. Johnson,et al. Trial of chlorhexidine gluconate for fungal corneal ulcers. , 1997, Ophthalmic epidemiology.
[25] D. Jones,et al. Fusarium solani keratitis treated with natamycin (pimaricin): eighteen consecutive cases. , 1972, Archives of ophthalmology.